Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Items 201–300 of 637
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Bjerner, J., Biernat, D., Fosså, S. D., & Bjøro, T. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365510903380886 · Cited by 43
“Since testosterone is associated with metabolism and body mass, low testosterone levels represent a risk factor for diabetes mellitus and metabolic syndrome [7,8].”
BackgroundHo, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40
“The free testosterone concentration calculated by this formula correlate well with the concentrations measured by equilibrium dialysis and ammonium sulfate precipitation, respectively [15], and the formula has been widely adopted by other investigators [1,2,13].”
BackgroundMethodKnapp, A., Myhill, P. C., Davis, W. A., Peters, K. E., Hillman, D., Hamilton, E. J., Lim, E. M., & Davis, T. M. E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12401 · Cited by 39
Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism
Almehmadi, Y., Yassin, D., & Yassin, A. A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1046044 · Cited by 41
Morales, Á., Bella, A. J., Chun, S., Jc, L., Assimakopoulos, P., Bebb, R. A., Gottesman, I. S., Alarie, P., Dugré, H., & Elliott, S. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.880 · Cited by 41
Prevalence of Hypogonadism in Patients with Type 2 Diabetes Mellitus in an Asian Indian Study Group
Ganesh, H. K., Sarathi, V., George, J., Shivane, V. K., Bandgar, T., Menon, P. S., & Shah, N. S. (2009) · Endocrine Practice · doi:10.4158/ep09035.orr · Cited by 40
Low Testosterone and the Association With Type 2 Diabetes
Farrell, J. A. B., Deshmukh, A., & Baghaie, A. A. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708323100 · Cited by 42
“Testosterone levels were not associated with HbA1c, duration of diabetes, or presence of diabetic complications.(23) Recent work from the Third National Health and Nutrition Examination Survey showed that low free and bioavailable testosterone levels were associated with diabetes, independent of adiposity.”
BackgroundInfluentialTint, A. N., Hoermann, R., Wong, H., Ekinci, E. I., MacIsaac, R. J., Jerums, G., Zajac, J. D., & Grossmann, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0672 · Cited by 38
Ho, C., Jaw, F.-S., Wu, C., Chen, K., Wang, C., Hsieh, J., Yu, H., & Liu, S. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12777 · Cited by 39
Hypogonadotrophic hypogonadism in type 2 diabetes
Dandona, P., Dhindsa, S., Chaudhuri, A., Bhatia, V., & Topiwala, S. (2008) · The Aging Male · doi:10.1080/13685530802317934 · Cited by 42
“The first study to report the prevalence of hypogonadism in T2D based on appropriately FT measured by equilibrium dialysis was published in 2004 [5].”
BackgroundMethodSelf-citationSystematic Literature Review of the Epidemiology of Nongenetic Forms of Hypogonadism in Adult Males
Zarotsky, V., Huang, M., Carman, W. J., Morgentaler, A., Singhal, P. K., Coffin, D., & Jones, T. H. (2014) · Journal of Hormones · doi:10.1155/2014/190347 · Cited by 43
“4% to above 45% [23, 25, 29, 36, 40, 45, 47, 48, 50, 56, 61, 71, 87] varying based on the definition of hypogonadism used: prevalence ranged from4.”
InfluentialJanjgava, S., Zerekidze, T., Uchava, L., Giorgadze, E., & Asatiani, K. (2014) · European journal of medical research · doi:10.1186/s40001-014-0056-6 · Cited by 41
“Abbreviations AH: Arterial Hypertension; BMI: Body mass index; CI: Confidence interval; COPD: Chronic obstructive pulmonary disease; CVD: Cardio-vascular disease; DP: Diastolic pressure; ECG: Electrocardiogram; ED: Erectile dysfunction; FSH: Follicle stimulation hormone; HbA1c: Glycosylated hemoglobin A1; HDL: High de…”
InfluentialMiner, M. M., & Seftel, A. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01317.x · Cited by 39
The CATCH checklist to investigate adult‐onset hypogonadism
Defeudis, G., Mazzilli, R., Gianfrilli, D., Lenzi, A., & Isidori, A. M. (2018) · Andrology · doi:10.1111/andr.12506 · Cited by 38
Topical Fluoxetine as a Novel Therapeutic That Improves Wound Healing in Diabetic Mice
Nguyen, C., Tartar, D. M., Bagood, M. D., So, M., Nguyen, A. V., Gallegos, A., Fregoso, D. R., Serrano, J. I., Nguyen, D., Degovics, D., et al. (2019) · Diabetes · doi:10.2337/db18-1146 · Cited by 40
“In humans, lower total testosterone levels commonly occur with type 2 diabetes (29), which may influence wound healing outcomes.”
BackgroundDhindsa, S., Reddy, A., Karam, J. S., Bilkis, S., Chaurasia, A., Mehta, A., Raja, K., Batra, M., & Dandona, P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0359 · Cited by 37
“This is consistent with the prevalence described in type 2 diabetic men without CKD (2, 3, 6).”
Self-citationSerum testosterone levels in diabetic men with and without erectile dysfunction
Ghazi, S., Zohdy, W., Elkhiat, Y., & Shamloul, R. M. (2012) · Andrologia · doi:10.1111/j.1439-0272.2012.01292.x · Cited by 39
“, 2005), dyslipidaemia and plasma glucose (Dhindsa et al., 2004) confirms the relationship between low values of this hormone and the development of CVD.”
BackgroundResultInfluentialHernández‐Mijares, A., García-Malpartida, K., Solá-Izquierdo, E., Bañuls, C., Rocha, M., Gómez-Martínez, M. J., Mármol, R., & Víctor, V. M. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01705.x · Cited by 38
Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices
Miner, M. M., Canty, D. J., & Shabsigh, R. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1914 · Cited by 36
Elevated high sensitivity C-reactive protein levels in aging men with low testosterone
Kaplan, S. A., Johnson‐Levonas, A. O., Lin, J., Shah, A. K., & Meehan, A. G. (2009) · The Aging Male · doi:10.3109/13685530903440424 · Cited by 39
Birkebæk, N., Lange, A., Holland‐Fischer, P., Kristensen, K., Rittig, S., Vilstrup, H., Handberg, A., & Grønbæk, H. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0538 · Cited by 35
Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?
Kong, A. P. S., Luk, A. O. Y., & Chan, J. C. N. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.003 · Cited by 39
Type 2 diabetes‐associated androgen alteration in patients with erectile dysfunction
El‐Sakka, A. I., Sayed, H. M., & Tayeb, K. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00815.x · Cited by 38
Early Menopause in Type 2 Diabetes – A Study from a South Indian Tertiary Care Centre
Medarametla, S. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14181.6628 · Cited by 43
“Some studies revealed lower levels of sex hormone binding globulin, estradiol, hypothalamic-pituitary hypofunction and hyperandrogenism in women with type-2 diabetes mellitus [12,13].”
BackgroundAntinozzi, C., Marampon, F., Corinaldesi, C., Vicini, E., Sgrò, P., Vannelli, G. B., Lenzi, A., Crescioli, C., & Luigi, L. D. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0686-y · Cited by 35
“Inversely, type 2 diabetes is frequently associated to reduced T levels [28].”
BackgroundSexual Dysfunction and Hypogonadism in Men With Diabetes
Bebb, R. A., Millar, A. C., & Brock, G. B. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.035 · Cited by 41
Souteiro, P., Belo, S., Oliveira, S. C., Neves, J. S., Magalhães, D. M. D. S., Pedro, J. M. P., Bettencourt‐Silva, R., Costa, M. M., Varela, A. T. I. F., Queirós, J., et al. (2018) · Andrologia · doi:10.1111/and.13035 · Cited by 36
“Additionally, insulin resistance is associated with a reduction in Leydig cell T secretion, and hyperinsulinism could induce DAX-1 expression in Leydig cells and inhibit steroidogenesis in mice, supporting that insulin resistance can also have a hypergonadotropic role in MOSH (Ahn et al., 2013; Pitteloud et al., 2005).”
BackgroundInfluentialSerum free testosterone and metabolic syndrome in Japanese men
Katabami, T., Kato, H., Asahina, T., Hinohara, S., Shin, T., Kawata, T., Ohta, A., Iwamoto, T., & Tanaka, Y. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-018 · Cited by 34
Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney
Xu, Q. S., Prabhu, A., Xu, S., Manigrasso, M. B., & Maric, C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00135.2009 · Cited by 34
“LOW TESTOSTERONE LEVELS are commonly observed in men with both type 1 (7) and type 2 diabetes with or without renal complications (5, 7).”
BackgroundHypoandrogen-metabolic syndrome: a potentially common and underdiagnosed condition in men
Gould, D. C., Kirby, R. S., & Amoroso, P. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01239.x · Cited by 37
Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status
Ng Tang Fui, M., Hoermann, R., Cheung, A. S., Gianatti, E. J., Zajac, J. D., & Grossmann, M. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00124.x · Cited by 33
“INTRODUCTION Cross-sectional studies have consistently reported that 30–50% of ageing, obese men with type 2 diabetes (T2D) have lowered serum testosterone levels, relative to reference ranges based on healthy young men (Dhindsa et al., 2004; Kapoor et al., 2007; Grossmann et al., 2008).”
BackgroundResultEhala-Aleksejev, K., & Punab, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194395 · Cited by 35
Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome
Louters, M., Pearlman, M., Solsrud, E., & Pearlman, A. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00496-7 · Cited by 32
“In western countries, there has been an increase in production and consumption of soy products with regular intake of soy isoflavones being associated with decreased risk of T2DM and CVD [34].”
BackgroundInfluentialRisk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
Zheng, R., Cao, L., Cao, W., Chu, X., Hu, Y., Zhang, H., Xu, J., Sun, H., Bao, W., Liu, K., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5162167 · Cited by 38
“In sum, hyperglycemia or diabetes can influence the hypothalamus-pituitary-gonad axis to cause hypogonadism [25, 30].”
BackgroundHypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover
Colleluori, G., Aguirre, L. E., Dorin, R. I., Robbins, D., Blevins, D., Barnouin, Y., Chen, R., Qualls, C., Villareal, D. T., & Armamento‐Villareal, R. (2017) · Bone · doi:10.1016/j.bone.2017.03.039 · Cited by 35
“Prior reports show that low testosterone can be found in 33% to as much as 64% [7,23,23,24] of patients with T2D suggesting that a significant number of men could be at a greater risk for fractures if indeed the presence of both conditions confers an even higher risk than either one alone.”
BackgroundVignera, S. L., Vicari, E. S. D., Condorelli, R. A., D’Agata, R., & Calogero, A. E. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.08.001 · Cited by 32
Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
Ogbera, A. O., Chinenye, S., Olufemi, F. A., & Ajala, W. (2011) · PubMed · Cited by 32
Metabolic syndrome and hypogonadism – two peas in a pod
Ebrahimi, F., & Christ‐Crain, M. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14283 · Cited by 36
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons
Morelli, A., Comeglio, P., Sarchielli, E., Cellai, I., Vignozzi, L., Vannelli, G. B., & Maggi, M. (2013) · International Journal of Endocrinology · doi:10.1155/2013/684659 · Cited by 33
Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know
Tamler, R., & Deveney, T. K. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2234 · Cited by 33
“testosterone levels and inappropriately low gonadotropin levels.(4,51,52) In one study of men with the triad of ED,”
BackgroundHernández, J. J. C., Almeida, M. D. G., Miralles, J. M., & Órfão, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.05.040 · Cited by 32
“In addition to monocytes, the following subsets of DC and lymphocytes were identified: [1] myeloid DC (CD33), [2] CD16þ DC (CD33þ, CD14-/dimþ), [3] plasmacytoid DC (CD33-/dimþ) (32, 33), [4] CD4þ/CD8- T cells, [5] CD8þ/ CD4- T lymphocytes, [6] CD4-/CD8- T cells, [7] CD4þ/ CD8þ T lymphocytes, [8] CD4-/CD8þ T cells, [9]…”
Aversa, A., Duca, Y., Condorelli, R. A., Calogero, A. E., & Vignera, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00225 · Cited by 35
Fu, H., Bai, X., Le, L., Tian, D., Gao, H., Qi, L., & Hu, K. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1782953 · Cited by 33
Ermetici, F., Donadio, F., Iorio, L., Malavazos, A. E., Dolci, A., Peverelli, E., Barbieri, A. M., Morricone, L. F., Chiodini, I., Arosio, M., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0203 · Cited by 35
Testosterone and erectile physiology
Guay, A. T. (2006) · The Aging Male · doi:10.1080/13685530601051155 · Cited by 34
“7% if total testosterone measurements were used) [20].”
MethodAssociation between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 33
“Some of the postulated mechanisms for this inverse relationship include (I) lower circulating testosterone levels among patients with diabetes and therefore decreased stimulation of the prostate (119); (II) detection bias secondary to fewer diabetes men getting prostate biopsies, even with elevated PSA (120).”
BackgroundWagner, I. V., Klöting, N., Savchuk, I., Eifler, L. K., Kulle, A. E., Kralisch-Jäcklein, S., Dötsch, J., Hiort, O., Svechnikov, K., & Söder, O. (2021) · Endocrinology · doi:10.1210/endocr/bqab017 · Cited by 29
“Other investigators were also able to show decreased serum testosterone concentrations in diabetic rats (43, 46, 49-52) and in humans with diabetes (53-56).”
BackgroundSridhar, S., Walia, R., Sachdeva, N. K., & Bhansali, A. K. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04510.x · Cited by 29
Androgen deficiency and type 2 diabetes mellitus
Gibb, F. W., & Strachan, M. W. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.004 · Cited by 31
Jeong, I. G., Hwang, S.-S., Kim, H. K., Ahn, H., & Kim, C. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0760 · Cited by 33
“Furthermore, low serum testosterone levels are associated with obesity, insulin resistance, type 2 diabetes, and metabolic syndrome (26-33).”
BackgroundDalvi, M., Walker, B. R., Strachan, M. W. J., Zammitt, N. N., & Gibb, F. W. (2016) · Clinical Endocrinology · doi:10.1111/cen.13015 · Cited by 29
Hormones, Metabolism, Aging and Men's Health
Buvat, J., Shabsigh, R., Guay, A. T., Gooren, L. J., Torres, L. O., MEULEMAN, E. J. H., & Graziottin, A. (2006) · Wiley eBooks · doi:10.1002/9780470755235.ch18 · Cited by 30
Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes
Saghier, E. O. A. E., Shebl, S. E., Fawzy, O., Eltayeb, L. M., Bekhet, L. M. A., & Gharib, A. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s27700 · Cited by 31
Malik, R. D., Lapin, B. R., Wang, C. E., Lakeman, J. C., & Helfand, B. T. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12730 · Cited by 30
Liu, R., Chung, M., Chuang, Y., Lee, J., Lee, W., Chang, H.-W., Yang, K. D., & Chancellor, M. B. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02738.x · Cited by 30
Li, C., & Xu, J. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01353-5 · Cited by 27
“Furthermore, hypogonadism is common in males with type 2 diabetes mellitus (T2DM), and about one-third of males with T2DM have low serum testosterone levels [10].”
BackgroundHypogonadism and metabolic syndrome: review and update
Berg, W. T., & Miner, M. M. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000582 · Cited by 26
Grossmann, M., Jayasena, C. N., & Anawalt, B. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad180 · Cited by 25
Advances in male hormone substitution therapy
Qoubaitary, A., Swerdloff, R. S., & Wang, C. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1493 · Cited by 26
“Recent studies reported a high incidence of hypogonadism in Type 2 diabetes mellitus [85,87,88], and treatment with testosterone in a very small study did not alter glycaemic”
BackgroundIGF-I, insulin and prostate cancer
Lima, G. A. B., Corrêa, L. L., Gabrich, R., de Miranda, L. C. D., & Gadelha, M. R. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800010 · Cited by 33
Oladele, C. A., Akintayo, C. O., Badejogbin, O. C., Oniyide, A. A., Omoaghe, A. O., Agunbiade, T. B., & Olaniyi, K. S. (2021) · Andrologia · doi:10.1111/and.14242 · Cited by 24
The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
Gunter, J. H., Lubik, A. A., McKenzie, I., Pollak, M., & Nelson, C. C. (2012) · Advances in Urology · doi:10.1155/2012/248607 · Cited by 28
“Hypogonadism as a result of age or in lean men with type 2 diabetes is likewise associated with reduced levels of oestradiol suggesting that decreased testosterone levels in these men is not likely to be due to oestradiol-mediated suppression of LHRH secretion [62, 68].”
BackgroundTestosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes
Colleluori, G., Aguirre, L. E., Napoli, N., Qualls, C., Villareal, D. T., & Armamento‐Villareal, R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab181 · Cited by 24
Hong, S. K., Oh, J. J., Byun, S., Hwang, S. I., Lee, H. J., Choe, G., & Lee, S. E. (2011) · The Prostate · doi:10.1002/pros.21405 · Cited by 25
New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
Karakas, S. E., & Surampudi, P. N. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.06.001 · Cited by 25
The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population
Rabijewski, M., Papierska, L., Zgliczyński, W., & Piątkiewicz, P. (2013) · BioMed Research International · doi:10.1155/2013/767496 · Cited by 24
“to body mass index (BMI), but the testosterone deficiency in T2DM was not dependent upon obesity, because 25% of nonobese patients also had HH [8].”
BackgroundEl‐Sakka, A. I., Sayed, H. M., & Tayeb, K. A. (2009) · Urology · doi:10.1016/j.urology.2009.02.077 · Cited by 28
Contreras, P. H., Serrano, F. G., Salgado, A. M., & Vigil, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00190 · Cited by 23
“reported that male hypogonadism is a frequent finding among type 2 diabetes patients (8).”
BackgroundOlivares, A., Méndez, J. P., Cárdenas, M., Oviedo, N., Palomino, M. Á., Santos, I., Perera-Marín, G., Gutiérrez‐Sagal, R., & Ulloa‐Aguirre, A. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.12.021 · Cited by 22
Clinical and biochemical correlates of male hypogonadism in type 2 diabetes
Herrero, A., Marcos, M., Galindo‐Villardón, P., Miralles, J. M., & Hernández, J. J. C. (2017) · Andrology · doi:10.1111/andr.12433 · Cited by 23
“…in non-diabetic men (Zarotsky et al., 2014) Neuropathy was a factor related with low testosterone levels in two studies (Hern andez-Mijares et al., 2010; Al Hayek et al., 2013), but it was not associated in our study and others (Dhindsa et al., 2004; Ganesh et al., 2009; Zheng et al., 2016).”
BackgroundResultInfluentialMen’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
Miner, M. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.003 · Cited by 23
“Among men with diabetes, the prevalence of hypogonadism has been reported to range from 20% to 64%.(61,62) A systematic review and meta-analysis of 43 prospective and crosssectional studies concluded that men with type 2 diabetes had significantly lower concentrations of testosterone than did men with normal fasting g…”
BackgroundHassan, J., & Barkin, J. (2016) · PubMed · Cited by 28
Is there a relationship between varicocele and testosterone levels?
Panach‐Navarrete, J., Morales-Giraldo, A., Ferrandis-Cortés, C., García-Morata, F., Pastor-Lence, J. C., & Martínez‐Jabaloyas, J. M. (2019) · The Aging Male · doi:10.1080/13685538.2018.1550745 · Cited by 21
“between 25 and 40% in diabetic men [28].”
BackgroundAndrogen deficiency and hormone‐replacement therapy
Isidori, A. M., Greco, E. A., & Aversa, A. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05603.x · Cited by 25
Male gonadal axis function in patients with type 2 diabetes
Costanzo, P., & Knoblovits, P. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0014 · Cited by 22
Zhang, K.-S., Zhao, M.-J., An, Q., Jia, Y.-F., Fu, L.-L., Xu, J.-F., & Gu, Y.-Q. (2018) · Andrology · doi:10.1111/andr.12425 · Cited by 20
“…is observed among men with © 2017 American Society of Andrology and European Academy of Andrology Andrology, 2018, 6, 37–46 37 ISSN: 2047-2919 ANDROLOGY T2DM, ranging from 25 to 40% (Dhindsa et al., 2004; Grossmann et al., 2008) and reaching 50% if obesity is associated (Saboor Aftab et al., 2013).”
BackgroundThe effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease
Aleksova, J., Ebeling, P., & Elder, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01083-8 · Cited by 20
“Low testosterone values are reported in 30–50% of men with T2DM, with a greater prevalence in patients aged over 65 years 139,140 .”
Dehydroepiandrosterone and Erectile Function: A Review
El-Sakka, A. I. (2018) · The World Journal of Men's Health · doi:10.5534/wjmh.180005 · Cited by 20
“It has been shown that androgen deficiency in type 2 DM is commonly associated with hypogonadotropic hypogonadism [67].”
BackgroundLiu, T., Wang, Y., Qian, B., & Li, P. (2024) · BioMed Research International · doi:10.1155/2024/6640796 · Cited by 23
“Chronic hyperglycemia plays an inhibitory e ff ect on the hypothalamic-pituitary-gonadal axis [53].”
BackgroundThe Prevalence and Predictors of Androgen Deficiency in Taiwanese Men With Type 2 Diabetes
Liu, R., Chung, M., Wang, P., Chen, C., Lee, J., Lee, W., Chancellor, M. B., Yang, K. D., & Chuang, Y. (2013) · Urology · doi:10.1016/j.urology.2013.03.023 · Cited by 21
Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population
Anupam, B., Shivaprasad, C., Vijaya, S., Atluri, S., Aiswarya, Y., & Nikhil, K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.006 · Cited by 21
Teoh, J. Y., Chiu, P. K., Chan, S. Y. S., Poon, D. M. C., Cheung, H.-Y., Hou, S. S. M., & Ng, C. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12226 · Cited by 22
“In a prospective study including 103 male patients, Dhindsa et al.(43) demonstrated the frequent occurrence of hypogonadotropic hypogonadism in patients with type 2 DM.”
BackgroundAnti-Pituitary Antibodies and Hypogonadotropic Hypogonadism in Type 2 Diabetes: In Search of a Role
Bellastella, G., Maiorino, M. I., Olita, L., Bellis, A. D., Giugliano, D., & Esposito, K. (2013) · Diabetes Care · doi:10.2337/dc13-0637 · Cited by 20
Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes
Kelsey, M. M., Bjornstad, P., McFann, K., & Nadeau, K. J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12255 · Cited by 20
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 24
Wu, Y.-C., & Sung, W.-W. (2024) · Pharmaceuticals · doi:10.3390/ph17091233 · Cited by 15
“Low testosterone levels are common in patients with T2DM [12].”
BackgroundAlbisinni, S., Nunzio, C. D., Tubaro, A., Barry, W. T., Bañez, L. L., & Freedland, S. J. (2012) · Urology · doi:10.1016/j.urology.2012.01.068 · Cited by 19
Hamilton, E. J., Davis, W. A., Makepeace, A., Lim, E. M., Yeap, B. B., Peters, K. E., & Davis, T. M. E. (2016) · Clinical Endocrinology · doi:10.1111/cen.13087 · Cited by 19
Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia
Hayek, A. A., Robert, A. A., Alshammari, G., Hakami, H., & Dawish, M. A. A. (2017) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551417710209 · Cited by 21
Effects of androgens on glucose metabolism
Umapathysivam, M. M., Grossmann, M., & Wittert, G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101654 · Cited by 19
Umoh, U., Davies, C. J., & Adeleye, J. (2010) · Cited by 20
Androgen deficiency in the aging man.
Arianayagam, R., Arianayagam, M., McGrath, S., & Rashid, P. (2010) · PubMed · Cited by 19
Huffman, J. N., Hoffmann, C., & Taylor, G. T. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i2.45 · Cited by 21
Male hypogonadism: 14‐year prospective outcome in 550 men with type 2 diabetes
Malipatil, N. S., Yadegarfar, G., Lunt, M., Keevil, B. G., Siddals, K. W., Livingston, M. A., Roberts, S., Narayanan, R. P., Rutter, M. K., Gibson, M., et al. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.64 · Cited by 17
Liu, Q., Huang, Y., Wang, M., Jiang, H., & Zhang, X. (2022) · Andrology · doi:10.1111/andr.13355 · Cited by 17
Rabijewski, M., Papierska, L., Kuczerowski, R., & Piątkiewicz, P. (2015) · The Aging Male · doi:10.3109/13685538.2015.1083972 · Cited by 19
“Low testosterone levels in T2DM are present in 25–40% of patients [8,9] and associated with symptoms of hypogonadism.”
BackgroundKaplan, S. A., Lin, J., Johnson‐Levonas, A. O., Shah, A. K., & Meehan, A. G. (2010) · The Aging Male · doi:10.3109/13685530903536676 · Cited by 18
Theodoraki, A., & Bouloux, P.-M. G. (2009) · Menopause international · doi:10.1258/mi.2009.009025 · Cited by 17
Degechisa, S. T., Kinde, S., Dedefo, G., Mudi, K., & Tarekegn, G. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1541668 · Cited by 19
“This variable also did not correlate with TT in similar studies conducted in South Africa and New York.(16,17) In contrast to this study, a study conducted in Jordan reported a significant positive correlation of age with TT.”
ResultCastro, M. A., Corrales, E. P., Cancela, A. A., Duque, S. G., Urzaiz, L. L., & Berrocal, V. R. (2020) · Endocrine · doi:10.1007/s12020-020-02455-6 · Cited by 16
“Furthermore, diabetes may cause hypogonadism through multiple mechanisms including suppression of hypothalamic gonadotrophin-releasing hormone (GnRH) secretion, or direct disruption of spermatogenesis [36].”
Background
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.